Sonnet 5 ships as Washington frees Fable
Anthropic launched Sonnet 5, a mid-tier model with improvements in agentic coding and reasoning, though its release is overshadowed by the imminent return of the more powerful Fable 5 and Mythos 5 models after export control restrictions were lifted. The newsletter also covers new AI tools from Google, Anthropic's Claude Science platform, and emerging developments in AI hardware and infrastructure.
Summary
Anthropic released Sonnet 5, positioned as 'the most agentic Sonnet model yet,' offering significant improvements in agentic coding and reasoning capabilities over its predecessor Sonnet 4.6. The model can operate browsers and terminals for extended tasks, bringing Opus-style agent behavior to a cheaper tier. However, its cybersecurity benchmarks are worse than Sonnet 4.6, with Anthropic noting they 'did not deliberately train' the model on cybersecurity tasks—an acknowledgment of constraints related to export controls on more powerful models. Pricing is set at $2/$10 per M input/output tokens through August 31, then $3/$15 after. The release feels underwhelming given that the U.S. Department of Commerce just lifted export controls on Fable 5 and Mythos 5, allowing those models to return online, shifting user attention away from Sonnet 5.
Google introduced two new media models: Nano Banana 2 Lite for cost-effective bulk image generation at $.034 per image with 4-second generation time, and Gemini Omni Flash for video generation and editing of 10-second clips at $.10/second. Omni Flash ranks among the top text-to-video models, trailing only Seedance 2.0 in video editing capabilities. The models are designed to work together in a unified workflow.
Ananthropic launched Claude Science, an AI workspace for scientific research that integrates paper review, databases, figure-making, and computing jobs. The platform connects 60+ scientific sources and tools for genetics, proteins, chemistry, and cell data, with auditable tracking of research steps. Anthropic is also launching its own preclinical drug discovery program targeting neglected diseases. The company hired Nobel laureate John Jumper from DeepMind, signaling a significant shift toward life sciences and scientific AI applications.
Additionally, the newsletter covers a guide for using Claude with the Goose Ads skill to generate brand-targeted ad creatives, and highlights a reader's workflow using ChatGPT combined with a Google spreadsheet backend for personalized nutrition coaching to support marathon training.
About this episode
PLUS: Create winning ads with Claude in one command
Key Insights
- Anthropic deliberately deprioritized cybersecurity capabilities in Sonnet 5 due to export control constraints on more powerful models, resulting in worse benchmarks than its predecessor.
- The return of Fable 5 and Mythos 5 after 18 days of export control restrictions is creating diminished interest in Sonnet 5 despite its genuine improvements over prior mid-tier models.
- Google's strategy links two models at different performance tiers—low-cost Nano Banana Lite for bulk generation and Omni Flash for advanced editing—enabling a unified creative workflow.
- Anthropic is shifting from a general-purpose AI company toward life sciences and scientific research, evidenced by hiring Nobel laureate John Jumper and launching Claude Science with an in-house drug discovery program.
- Claude Science provides auditable tracking of research workflows across 60+ scientific data sources, addressing the need for reproducibility and fact-checking in scientific work.
Topics
Transcript
Good morning, {{ first_name | AI enthusiasts }}. Anthropic's first model in its '5' tier is here… But it won’t be holding the spotlight for long. The newly released Sonnet 5 is an upgrade over its predecessor, but not at the levels we’ve become accustomed to — and it arrives at a bit of an awkward moment with the far more powerful and celebrated Fable and Mythos models now officially set to return. Editor’s Note: Anthropic announced Tuesday night that the Department of Commerce has lifted its export controls on Fable 5 and Mythos 5, with the models set to come back online Wednesday. We'll have deeper coverage on this in the next edition. Anthropic's Sonnet 5 arrives in Fable's…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The Rundown AI
Grok 4.6 storms the AI frontier
SpaceXAI's Grok 4.6 has emerged as a competitive frontier AI model, scoring 61 on benchmarks and undercutting rivals on price at 60% less cost, with Grok 4.7 teased for release in 3-4 weeks. The newsletter covers AI trends including practical guidance on using AI effectively, a personalized cancer vaccine startup for dogs built with AI tools, and updates on competing models and AI products.
Anthropic slips an invisible signature into Claude
Anthropic has announced the implementation of invisible watermarks in outputs from its Claude models to enhance transparency, aligning with the EU AI Act. The move has sparked mixed reactions, as stakeholders navigate the implications for open and private AI models.
Meta returns to its open-source roots
Meta is returning to its open-source roots with the launch of the Muse Glimmer model and plans for Muse Spark 1.2, positioning itself as a competitive force against China's AI dominance. OpenAI has also expanded its security program with a new hacking-tuned model, indicating a growing emphasis on cybersecurity in AI deployments.
OpenAI puts the safety brakes on Astra
OpenAI's Astra model, rumored to be GPT-6, is being treated as a potential 'critical' cyber risk following its success in solving significant problems, prompting increased safeguards and a delay in its rollout. This decision reflects broader concerns about AI's evolving capabilities and associated security risks as evidenced by recent breaches in the AI community.
AI designs viruses never seen in nature
Researchers used AI to design 16 novel viruses that infect only bacteria, successfully creating them in the lab to combat drug-resistant infections. While the work demonstrates beneficial applications, experts warn that the same AI tools could be repurposed to create dangerous pathogens, prompting calls for biosafety guardrails.